accountat the Reuters Health Summit on Wednesday. He expects aggregate industry sales growth for the top 25 global pharmaceutical companies of between zero and 1 percent a year through 2016, compared with annual sales growth of 6 to 7 percent in the previous...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Bain sees stagnant pharma sales for next 5 years
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account